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Conclusion: DBBM utilized as sole grafting material in staged MSFA 
demonstrated to be clinically effective regardless of the healing period. 
Histomorphometrical and micro-CT assessments revealed that at later 
stages of healing (8 and 11 months) there is a higher proportion of newly-
bone formation compared to earlier stages (5 months). Moreover, the 
longer the maturation period, the substantially lesser remaining biomaterial 
could be expected. Even though, these facts did not seem to negatively 
impact on the implant prognosis 1-year after loading.  
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Influence of Healing Period upon Bone Turn Over on Maxillary Sinus Floor 
Augmentation Grafted Solely with Deproteinized Bovine Bone Mineral: A Prospective 
Human Histological and Clinical Trial 
Abstract 
Purpose: To investigate the influence of maturation timing upon histological, 
histomorphometric and clinical outcomes when deproteinized bovine bone mineral (DBBM) 
was used as a sole biomaterial for staged maxillary sinus floor augmentation (MSFA).  
Materials and methods: Patients with a posterior edentulous maxillary situation and a 
vertical bone height ≤ 4 mm were included in this study. A staged MSFA was carried out. 
After MSFA with DBBM as a sole grafting material, biopsy cores were harvested with 
simultaneous implant placement followed by a healing period of 5, 8, and 11 months, 
respectively. Micro-CT, histologic and histomorphometric analyses were performed. 
Results: Forty-one patients were enrolled and 38 bone core biopsies were harvested. 
Significantly greater BV/TV was observed between 5- and 8-month healing from micro-CT 
analysis. Histomorphometric analyses showed the ratio of mineralized newly formed bone 
increased slightly from 5 to 11 months; however, no statistically significant difference was 
reached (p=0.409). Residual bone substitute decreased from 37.3±5.04% to 20.6±7.45%, 
achieving a statistical significant difference from of 5 up to 11 months (p<0.01). Moreover, no 
implant failure, biological or technical complication occurred after 12-month follow-up of 
functional loading. 
Conclusion: DBBM utilized as sole grafting material in staged MSFA demonstrated to be 
clinically effective regardless of the healing period. Histomorphometrical and micro-CT 
assessments revealed that at later stages of healing (8 and 11 months) there is a higher 
proportion of newly-bone formation compared to earlier stages (5 months). Moreover, the 
longer the maturation period, the substantially lesser remaining biomaterial could be expected. 
Even though, these facts did not seem to negatively impact on the implant prognosis 1-year 
after loading. 
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rate; maxillary sinus floor augmentation 
 
 
Introduction 
Insufficient bone volume is a common finding encountered in the rehabilitation of the 
edentulous posterior maxillae with implant-supported prostheses. Bone volume is limited by 
the pneumatization of the maxillary sinus together with loss of alveolar bone height.1,2 Sinus 
lifting procedures aim at increasing bone volume by augmenting the sinus cavity with 
autogenous bone or bone grafting biomaterials, or a mixture of both for adequate implant 
placement. 3 
 
Maxillary sinus floor augmentation (MSFA) is performed as a one- or two- staged approach 
with simultaneous or delayed implant placement.4 Generally speaking, with a residual bone 
height of less than 5mm, staged augmentation and implantation is advised considering the 
requirement of adequate implant primary stability to achieve subsequent osseointegration.
5 
 
Nowadays, a wide variety of bone substitute materials have been clinically demonstrated to 
promote acceptable outcomes in MSFA.
 6-9
 Deproteinized bovine bone mineral (DBBM) is a 
clinically broadly used bone substitute in sinus augmentation and other ridge augmentation 
procedures. It has the property of slow resorption rate and has shown to have the potential to 
be colonized by osteocytes CD-44 positive to promote neovascularization within the 
particles.
10,11
 The advantage of using bone substitutes as sole grafting material before implant 
surgery is evident, as no donor site for harvesting autogenous bone is necessary.12 Questions 
remain as to whether there is a significant positive impact to mixing bone substitutes like 
DBBM with autogenous bone over using DBBM alone for sinus augmentation.  
 
Several clinical human studies have reported on the efficacy of DBBM used alone in MSFA. 
Bassil et al. conducted a histological analysis of human bone cores, which were harvested 
from augmented sinus using DBBM (Bio-Oss®) alone. After 8 months of healing, an average 
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percentage of newly formed bone was 17.6%±2.8% and a proportion of residual bone 
substitute material was 29.9%±4.9%.13 Similar results were also achieved from another 
human study by Lee et al. After a healing period of 9 months using again Bio-Oss
®
 alone, the 
percentages of regenerated bone and residual graft material was 19% and 40%, respectively.14 
Meanwhile, implant placed into this regenerated bone had survival rates of 100% in both 
studies.
13,14 
Hence, the evidence of the aforementioned studies showed that the use of DBBM 
alone in MSFA is a predictable method to gain vertical bone height in the posterior maxilla 
while adequate bone turn over occurs. Nevertheless, DBBM only has osteoconductive 
property and so whether de novo bone formation is decelerated without the autologous bone 
transplantation is still a matter of debate in such a contained cavity as it is the maxillary 
sinus.15, 16 As such, in an animal study, when an equal proportion of Bio-Oss and autogenous 
iliac bone was used as grafting material, the proportion of newly formed bone increased to 52% 
after 6 weeks.
17
 It was considered that the addition of autogenous bone to DBBM might 
accelerate bone formation during the early healing events compared to DBBM alone. 
Therefore, the clinical and histological outcomes of implants inserted at different healing 
timings in augmented maxillary sinuses remain to be areas of further investigation.  
 
The primary outcome of the study herein was to investigate the influence of maturation 
timing upon histological, histomorphometric and clinical outcomes when deproteinized 
bovine bone mineral (DBBM) was used as a sole biomaterial for staged maxillary sinus floor 
augmentation (MSFA).  
 
Material and methods 
Study design 
This study was conducted from May 2014 to December 2015. The study design and clinical 
procedures were performed in accordance with Helsinki Declaration, and were approved by 
the Ethical Committee of Shanghai 9th People’s Hospital, China (Approval number: 01578). 
All patients signed the informed consent form before treatment. 
 
Inclusion and exclusion criteria  
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Patients were selected to participate whether their clinical condition met the following 
inclusion criteria:  
(1) Patients had to be over 18 years of age at the time of surgery 
(2) Implant therapy was required in the posterior maxilla to restore masticatory function 
(3) Systemic and local conditions compatible with implant placement and MSFA 
(4) Less than or equal to 4 mm alveolar vertical bone height from the crest of the residual 
alveolus to the sinus floor  
(5) A minimum of a 3-month healing period after tooth extraction was assumed 
(6) Adequate width of alveolar ridge (bone width > 7mm) without additional horizontal bone 
augmentation 
(7) Normal inter-arch relationship 
(8) Patients with chronic periodontitis had to have been treated as part of initial periodontal 
therapy 
 
Patients were excluded from the study for one or more of the following conditions: history of 
autoimmune or bone diseases, smoking, uncontrolled diabetes, radiation therapy, medication 
with steroids or bisphosphonates, untreated periodontal disease, or sinus infection.  
 
Conventional panoramic radiography and cone beam computed tomography (CBCT) (i-CAT 
FLX Cone Beam 3D system; Kavo, Biberach, Germany) were taken to evaluate the maxillary 
sinus cavity and its vicinity together with the vertical residual bone height in the edentulous 
areas. The residual bone height was measured at every pre-operatively planed implant site. 
 
Allocation and concealment 
Subjects eligible for this study were randomly assigned into three groups using the random 
numbers table by an assistant. Subjects were randomly assigned into three groups:  
• Group 1: staged MSFA  maturation phase of 5 months  implant placement 
• Group 2: staged MSFA  maturation phase of 8 months,  implant placement 
• Group 3: staged MSFA  maturation phase of 11 months  implant placement 
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The outcome examiner was blinded to the assignment. 
 
 
Surgical procedure 
MSFA were performed with simultaneous bone grafting according to the technique described 
by Tatum.18 Briefly, a full-thickness mucoperiosteal crestal incision and flap was made with 
vertical extensions and the lateral aspect of the maxilla was exposed. A window osteotomy 
was then prepared on the lateral aspect of the maxilla to access the maxillary sinus cavity. The 
Schneiderian membrane of the sinus was then gently reflected from the floor of the sinus 
cavity. The sinus cavity was then grafted under the elevated membrane by placing DBBM 
(Bio-Oss, Geistlich AG, Wohlhusen, Switzerland alone with a 1:1 ratio of 
0.25mm-1mm/1mm-2mm granules and was gently packed over the bone into the sinus. After 
placement of the graft, the sinus access window opening was then covered with a collagen 
membrane (Bio-Gide®; Geistlich AG, Wohlhusen, Switzerland), and the flap was sutured to 
attain primary closure.  
 
All patients received postoperative nose drops for 7 days (Xinya Co., Shanghai, China) and 
were instructed not to blow through the nose for 2 weeks. Amoxicillin (Xinya Co., Shanghai, 
China; 500 mg, 4 times a day for 7 days) and metronidazole (Xinyiwanxiang, Shanghai, 
China; 400 mg, 3 times a day for 7 days) were prescribed. A chlorhexidine oral rinse (0.12%) 
was also prescribed (60s, 5–6 times a day for 7 days). After 14 days, the sutures were 
removed.  
 
Implant placement and biopsy core harvesting 
For group 1 patients, after a healing of 5 months, implants were inserted into the augmented 
sinus according to implant system manufacturer instructions. A pre-operative CBCT served as 
an indicator for the augmented region prior implant insertion.  
 
Bone biopsy cores were removed with a trephine drill (outer diameter 3.0 mm, inner diameter 
2.0 mm, length 10 mm; Hager Meisinger, Germany) from areas corresponding to where the 
implants were going to be placed and the region of the previous sinus graft. Bone biopsy 
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cores of approximately 2 x 10 mm in dimension were retrieved with a trephine drill. If 
multiple implants were planned, the core was taken from the site with the least pretreatment 
height of bone. Thus, each patient contributed only one biopsy for analysis.  
 
The bone biopsy cores were immediately fixed in 10% neutral-buffered formalin to enable 
micro-CT and histomorphometric analyses. Oral implants (Straumann, Straumann AG, Basel, 
Switzerland) of 10 to 12 mm in length were placed in the grafted sites. MSFA, bone core 
biopsy and implant installations were performed by two surgeons. For group 2 and group 3 
patients, after a healing of 8 and 11 months respectively, the procedures including 
implantation and biopsies harvesting were performed by the same two surgeons. 
 
Micro-CT analysis  
Non-decalcified bone cores were scanned and the data quantified using Micro-CT (Scanco 
Medical AG, Fabrikweg 2, Bruttisellen, Switzerland). The specimens were fitted in a 
cylindrical sample holder (15.4 mm in diameter) with the longitudinal axis of the bone core in 
a horizontal position. Specimens were scanned with scanning direction parallel to the 
longitudinal axis of the core specimen. High-resolution scanning, with an in-plane pixel size 
and slice thickness of 25 µm was performed. Software was used to make 3-dimensional (3-D) 
reconstruction from the set of scans.   
 
The grafted sites were demarcated visually as the region located superior (apical) to the dense, 
mature lamellar bone and remnant DBBM particles with high density. The mean threshold 
gray scale values for bone and residual scaffold material were used to calculate the bone 
mineral density (BMD). The other morphometric variables analyzed included:  
- Bone volumetric fraction (BV/TV) refers to the total amount of bone present in relation to the 
analyzed bone volume.  
- Bone surface density (BS/TV) is the relation between the overall trabecular bone surface and 
the bone volume analyzed of mineralized bone. 
- Bone-specific surface (BS/BV) analyzed the relation between the trabecular bone surface and 
the mineralized bone.  
Page 9 of 25 Clinical Implant Dentistry and Related Research
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
 
Bone histomorphometry  
Bone cores were processed for histological analysis. Histomorphometric analysis of 
decalcified, hematoxylin and eosin (H&E)-stained sections was performed to determine 
newly bone formation and residual particles. Using a light microscope (BX51 Microscope, 
Olympus, Tokyo, Japan), histologic sections from each sample at each time point were 
scanned and imported into the software program (Image Pro 5.0, Media Cybernetic, Silver 
Springs, MD, USA). Identification of bone was based on morphology of stained tissue and 
the identification of grafting material, cells lining (osteoblasts) and within (osteocytes) this 
tissue. Bone tissue area for each section was determined by dividing the total number of bone 
pixels by the total number of pixels in the tissue section. To verify the accuracy and 
consistency of tracing outlines, three random slides were selected. The average of the three 
tracings per sample was obtained. Evaluation parameters included mineralized new bone 
volume/tissue volume, residual bone substitute material volume/tissue volume and 
inter-trabecular volume (bone marrow and soft tissue components)/tissue volume. 
 
Implant outcome assessment  
The follow-up examination was performed according to a standardized protocol, which 
included a clinical radiographic evaluation after delivering of the final prosthesis and one year 
follow-up.  
 
Peri-implant clinical parameters included bleeding on probing using the modified bleeding 
index; modified plaque index
19
 and probing depth. Peri-implant bone resorption was 
recorded by comparing standardized long cone peri-apical radiographs. All of the images 
were scanned and transferred to a computer with an image analysis program (GE Healthcare 
Centricity@ v3.0, Milwaukee, WI, USA). Marginal bone loss (MBL) was documented on the 
radiograph viewer with the aid of four-fold magnification. The radiographic linear distance 
from the implant shoulder to the first bone to implant contact was used to calculate the MBL. 
The location of the MBL in relation to the implant shoulder was assessed at the mesial and 
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the distal aspects at the time of prosthesis delivery and at 1-year follow-up radiograph. Two 
assistants conducted the radiographic assessment.  
 
Statistical analysis 
Statistical analysis was conducted with PASW Statistics 18.0 (SPSS Inc, Chicago, IL, USA). 
Plots represent means ± standard deviation (SD). Differences in means from micro-CT and 
histomorphometry analysis between 3 groups were assessed with one-way ANOVA. For 
non-parametric clinical parameters, the Kruskal-Wallis test was used to analyze differences 
among groups. In all tests, a significance level of 0.05 was chosen.  
 
Results 
Subject demographics  
After determination of study eligibility and enrollment, a total of 41 patients with 41 sinuses 
were treated and 70 implants were placed in the posterior maxilla as above described. The 
baseline demographic characteristics of all study participants are shown in Table 1. During 
MSFA, membrane perforation occurred in 5 of 41 sinuses. In the 5 cases, the perforation was 
patched with a portion of Bio-Gide membrane. The postoperative course after MSFA was 
uneventful in all cases. 
 
Forty-one bone samples were taken from the augmented maxillary sinus before implant 
placement. Three samples were lost during the extraction and 2 samples were not intact. On 
the other hand, a total of 38 bone core biopsies were available for analysis (Fig 1). Implants 
were inserted with sufficient primary stability after implant site preparation. 
 
Micro-CT analysis  
From sagittal-sectional imaging, micro-CT showed newly formed bone in sinus at 5 months 
post-operation (Fig 2). The characteristics of the newly formed bone were calculated by 
morphometric analysis among groups. BMD of the regenerated bone were 1132.7±102.28, 
1153.2±116.79, and 1053.2±163.89, meanwhile BV/TV were 43.8±18.69%, 64.15±5.71%, 
and 59.57±7.97% in group 1, group 2 and group 3, respectively. Significance of BV/TV was 
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observed between group 1 and group 2 after staged MSFA from micro-CT analysis (p=0.007). 
However, there is no significant difference in BMD, BS/TV and BS/BV amongst the groups. 
Moreover, although a positive trend was found with regards to BS/BV for group 1 
(10.78±3.05%) compared to group 2 and 3 (6.78±1.47% and 7.92±1.79%, respectively), no 
statistical significance was reached. Alike, no significant differences were noted in the other 
micro-ct parameters evaluated (Fig 3) 
 
Histomorphometric analysis  
For all 3 groups, DBBM displayed good tissue integrity and it was easy to distinguish 
between DBBM and de novo bone. Direct contact occurred between the substitutes and the 
superimposed newly formed bone. De novo bone formation around the bone substitute could 
be visualized as well (Figs 4). The ratio of mineralized new bone, residual bone substitute, 
bone marrow and soft tissue of 3 groups was listed in Table 2. While for the newly formed 
mineral tissue did not reach statistical significance (p=0.409), the residual bone substitute 
together with the bone marrow and soft tissue content demonstrated to significantly increase 
and decrease, respectively from group 1 up/down to 3. 
 
Implant outcome assessment 
Thirty-two implants were restored as 2–3 units fixed bridges, 6 as single-unit crowns. The 
average time to completion of the final prosthesis after implant placement was 4.3months (3-6 
months). No patient dropped out of the study at follow-up. There was no implant lost during 
healing period and after functional loading. The survival rate of implants was 100% during 
1-year follow-up. No biological (i.e. mucositis or peri-implantitis) or technical complications 
occurred. 
 
The mean mPI and mSBI was 0.3 and 0.5 at the 1-year follow-up. There was no statistical 
significant difference of mPI and mSBI among 3 groups. The kappa (j) values were >0.8 
showing good inter-examiner reliability. Upon analysis of the MBL obtained for mesial and 
distal peri-implant sites, no significant differences were detected between the values for the 
mesial and distal sites. The overall mean MBL of 38 implants was 0.8±0.17 mm (median: 0.8 
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mm). For the implants in group 1, group 2 and group 3, the mean MBL was 0.7±0.21 mm 
(median: 0.7 mm), 0.7±0.14 mm (median: 0.7 mm), and 0.8±0.15 mm (median: 0.8 mm), 
respectively. No significant difference was detected amongst the groups evaluated. 
 
Discussion 
Augmentation of maxillary sinus is a well-documented method for creating sufficient bone 
for the adequate placement of dental implants in the maxillary posterior region.3 Autogenous 
bone has long been considered the gold standard; nonetheless, bone harvesting increases 
surgical complexity and is associated with morbidity and scarring of the donor site.
20
 
Therefore, alternative grafting materials were developed to overcome above mentioned 
shortcomings. Xenografts such as the DBBM are derived from different species and its 
preservation process consists in the complete or partial thermo-chemical removal of the 
organic component eventually creating a mineral inert long-lasting scaffold.
21 
 
Galindo-Moreno et al. described the healing patterns and bone remodeling activity following 
the use of two different graft mixtures (50% autologous bone/50% DBBM and 20% 
autologous bone/80% DBBM) for MSFA. At 6-month post-grafting evaluation, no 
statistically significant differences were found between groups in regards to vital bone and 
non-mineralized tissue proportions. However, higher number of osteocyte was observed in 
specimens with 50% to 50% ratio.7 A recent literature review conducted by Jensen et al. 
compared the differences between the use of DBBM or DBBM mixed with autogenous bone 
as graft for MSFA in animal study. Fourteen studies using the lateral window technique for 
the MSFA were identified. It was found that the volumetric stability of the graft improved 
significantly with the increased proportion of DBBM in the graft. 22  
 
Several recent studies have confirmed the effect of the Schneiderian membrane on the 
formation of bone after MSFA.23-26 It was certainly found that, in vitro the Schneiderian 
membrane possess osteogenic capability and participates in the formation of bone after MSFA. 
However, the regenerative/reparative potential of the Schneiderian membrane in vivo has not 
been extensively evidenced.27-32 On the other side, understanding the maxillary sinus as a 
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contained defect, the adjacent walls are the major responsible for the nutrients and oxygen 
supply needed to achieve predictable regeneration at the early stages of healing.
27,31,33
  
From the clinical point of view, it is necessary to confirm the adequate healing timing for 
implant placement after MSFA with DBBM alone, and the clinical outcome of dental 
implants inserted in the ‘healed sinus’, since autogenous bone/DBBM ratio may dramatically 
impact on bone remodeling patterns and cell content following MSFA as shown in previous 
studies.8,17 
 
Nowadays, little information is available and mainly restricted to animal models on the use of 
DBBM alone. A rabbit study tested DBBM alone in the maxillary sinus. Animals were 
sacrificed at 1, 2, 4, 6, or 8 weeks after surgical procedure. New bone formation was revealed 
on the surface of DBBM particles from 2 weeks and continued up to 8 weeks. The newly 
formed bone was 4%, 14%, 22%, 23% at 2, 4, 6, 8 weeks respectively with 
histomorphometric analysis.33 Caneva et al. investigated the pattern of the sequential healing 
at augmented sinus cavities with DBBM granules as sole grafting material in the rabbit. 
Newly-formed mineralized bone increased from 5.2% up to 28.3% in the occupying areas of 
the elevated space at 7 days and 40 days healing.32 Such findings concur with the outcomes 
obtained in our investigation, where histomorphometrical analyses showed that the proportion 
of newly formed mineralized bone increased slightly from 18.0±6.04% to 21.3±7.08% from 5 
to 11 months of healing, although it did not reach statistical significance. In this sense, it must 
be emphasized that data obtained in animal models must be cautiously extrapolated to the 
human, since the healing duration widely varies.  
 
In our study, residual bone substitute decreased from 37.3±5.04% down to 20.6±7.45% from 
5 up to 11 months of healing reaching statistical significance. In the aspect of biodegradation 
of DBBM, at present, limited information was available and to the best of authors’ knowledge 
no study included quantitation over time in clinical trials. In an animal study, no significant 
differences in the proportion of remaining DBBM particles were revealed after 7.5 months 
and 1.5 year after MSFA.
34
 In Caneva et al. study, DBBM particles decreased from 56.8% 
down to 37.4% in 7 and 40 days of healing and it was further shown that DBBM was 
Page 14 of 25Clinical Implant Dentistry and Related Research
This article is protected by copyright. All rights reserved.
A
cc
ep
te
d 
A
rt
ic
le
beneficial since it efficiently assisted to preserve over time the space within the elevated 
mucosa.
32
 Nevertheless, it is still needed to investigate further to understand the performance 
of DBBM by means of newly bone formation and long-term volumetric stability of the graft 
in the human. In the present study without using autogenous bone, new bone regeneration 
seemed slower than the biodegradation of material, meaning that the percentage of soft tissue 
and void spaces increased during the healing phrase. 
 
In the clinical setting, volumetric stability of the grafted defects, survival rates of implants 
inserted into grafted sinus, as well as the prevalence of complications have been important 
considerations. In previous clinical human studies, high survival rate of dental implants 
placed in augmented sinus with DBBM alone have been reported.13,14 However, the healing 
timing before implant insertion was 8 and 9 months respectively.
 13,14 
Furthermore, the 
addition of autogenous iliac bone to DBBM might accelerate not only bone regeneration, but 
also the bone-to-implant contact during the early events of healing compared to DBBM 
alone.17, 35 That is to say, with absence of autogenous bone, the progress of osseointegration 
might be affected negatively. However, from our investigation, even if the healing period was 
shortened down to 5 months, the implants showed similar clinical performance compared to 
the ones inserted in the augmented sinuses with 8 and 11 months of healing. One interesting 
animal study studied the healing sequence of osseointegration at implant installed 
simultaneously in MSFA with DBBM. The authors considered that the osteoconductive 
properties of the implant surface contributed to the progression of the osseointegration for 
MSFA procedures with simultaneous implant placement.
31
 This has an important clinical 
implication in the duration of the therapy and it could provide actual benefits for the patients 
by shortening the treatment plan.  
 
Conclusion  
DBBM utilized as sole grafting material in staged MSFA demonstrated to be clinically 
effective regardless of the healing period. Histomorphometrical and micro-CT assessments 
revealed that at later stages of healing (8 and 11 months) there is a higher proportion of 
newly-bone formation compared to earlier stages (5 months). Moreover, the longer the 
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maturation period, the substantially lesser remaining biomaterial could be expected. Even 
though, these facts did not seem to negatively impact on the implant prognosis 1-year after 
loading. 
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Figure 1. Depiction of an augmented maxillary sinus and the selected region of interest to be 
analyzed solely consisting on the grafted area excluding the native bone. 
 
Figure 2. Micro-CT images of representative bone biopsies from group 1 patients clearly 
show residual grafted scaffold (DBBM) particles (red zone) in the grafted zone 5 months after 
grafting. The zone of regenerated bone is delineated from the native bone (yellow hashed 
line).  
 
Figure 3. Graph of the parameters studied by micro-ct analysis for the three groups: group 1= 
5-month healing; group 2= 7-month-healing; and group 3= 11-month healing. 
 
Figure 4. The DBBM (Bio-Oss
®
) particles were primarily incorporated in newly formed bone, 
whilst connective tissue surrounded the particles within the central part. 
# DBBM; * Mineralized new bone; § Bone marrow and soft tissue 
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Table 1. Patient demographic data 
  Group 1 Group 2 Group 3 
No. of patients enrolled  13 15 13 
Females  6 4 5 
Mean age ± SD, years (range)  45.2±11.9 
(22-61) 
44.1±14.0 
(23-60) 
46.4±11.7 
(23-62) 
Right maxilla/left maxilla   5/8 7/8 7/6 
Mean baseline alveolar bone height 
(range) 
 3.2(1.5-4) 2.0(1-4) 2.4(1-4) 
DBBM (g) (range)  2.3(2.0-3) 2.7(2.0-3.0) 2.5(2.0-3.0) 
Bone core sample No.  12 13 13 
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Table 2. Mean±SD (%) of different tissue proportions in staged MSFA with different healing 
period 
 
 Group 1 (12)* Group 2 (13) Group 3 (13) 
 Mean±SD (%) 
Mineralized new bone 18.0±6.04 20.6±5.17 21.3±7.08 
Residual bone substitute 37.3±5.04＃ 28.2±5.34＃ 20.6±7.45＃ 
Bone marrow and soft tissue 44.6±6.09& 51.0±5.83 58.1±6.60& 
* No. of samples; 
＃&
 p<0.05  
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Figure 1. Depiction of an augmented maxillary sinus and the selected region of interest to be analyzed solely 
consisting on the grafted area excluding the native bone.  
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Figure 2. Micro-CT images of representative bone biopsies from group 1 patients clearly show residual 
grafted scaffold (DBBM) particles (red zone) in the grafted zone 5 months after grafting. The zone of 
regenerated bone is delineated from the native bone (yellow hashed line).  
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Figure 3. Graph of the parameters studied by micro-ct analysis for the three groups: group 1= 5-month 
healing; group 2= 7-month-healing; and group 3= 11-month healing.  
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Figure 4. The DBBM (Bio-Oss®) particles were primarily incorporated in newly formed bone, whilst 
connective tissue surrounded the particles within the central part. # DBBM; * Mineralized new bone; § Bone 
marrow and soft tissue  
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